Pieris Pharmaceuticals, Inc. (PIRS)
| Market Cap | 288.19M |
| Revenue (ttm) | 23.73M |
| Net Income (ttm) | -48.35M |
| Shares Out | 61.91M |
| EPS (ttm) | -0.85 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 528,641 |
| Open | 4.37 |
| Previous Close | 4.41 |
| Day's Range | 4.23 - 4.41 |
| 52-Week Range | 1.70 - 6.15 |
| Beta | 1.20 |
| Analysts | Strong Buy |
| Price Target | 8.50 (+96.8%) |
| Est. Earnings Date | Nov 3, 2021 |
About PIRS
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin protein-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment o...
Financial Performance
In 2020, PIRS's revenue was $29.32 million, a decrease of -36.64% compared to the previous year's $46.28 million. Losses were -$37.23 million, 46.2% more than in 2019.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for PIRS stock is "Strong Buy." The 12-month stock price forecast is 8.50, which is an increase of 96.76% from the latest price.
News
7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
With so much chaos occurring on Wall Street, these lesser-known penny stocks to buy might fly profitably under the radar. The post 7 Penny Stocks to Buy to Sidestep the Noise on Wall Street appeared fir...
2 Penny Stocks That Could Soar Soon
These two tiny drugmakers might be hidden gems.
3 Biotech Stocks to Watch Now
Biotech companies develop new medicines, vaccines, or medical devices. They use advanced technologies and medical science to do so.
Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer
BOSTON, MA / ACCESSWIRE / October 6, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technol...
Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences
BOSTON, MA / ACCESSWIRE / September 9, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® techn...
Top Penny Stocks to Watch After the Long Weekend
Are these penny stocks on your watchlist this week? The post Top Penny Stocks to Watch After the Long Weekend appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Penny Stocks To Watch For September With Upcoming Events
These penny stocks could be in focus as we turn the page on a new month. The post 5 Penny Stocks To Watch For September With Upcoming Events appeared first on Penny Stocks to Buy, Picks, News and Inform...
Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor
BOSTON, MA / ACCESSWIRE / August 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technol...
Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Misses Revenue Estimates
Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -25.00% and -61.47%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Pieris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON WEDNESDAY, AUGUST 4, 2021 AT 8:00 AM EDT Announced inhaled program PRS-220 for the treatment of IPF and was selected to receive a Bavarian government grant...
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Tim Demuth, M.D., Ph.D., joins Pieris as Chief Medical Officer Shane Olwill, Ph.D.
Pieris Pharmaceuticals to Host Second Quarter 2021 Investor Call and Provide Corporate Update on August 4, 2021
BOSTON, MA / ACCESSWIRE / July 28, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...
This Risky Micro-Cap Could Pay Off Big
Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.
Pieris Stock Moves Higher On €14.2M Grant For PRS-220 In Post-COVID Pulmonary Fibrosis
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) has announced the development of PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor to treat idiopathic pulmonary fibrosis (IP...
Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Doll...
PRS-220, an oral inhaled Anticalin protein targeting CTGF, a fully proprietary drug candidate for respiratory disease, is being developed as a local treatment for idiopathic pulmonary fibrosis Grant to ...
Best Penny Stocks to Buy Right Now? 15 To Watch In July
These penny stocks are trending right now, here's why The post Best Penny Stocks to Buy Right Now? 15 To Watch In July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Top Stocks Under $10
Are you looking for cheap stocks with a lot of upside? Check out Rolls-Royce, Pieris Pharmaceuticals, and Kahoot!
Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer
BOSTON, MA / ACCESSWIRE / June 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technolog...
Best Biotech Penny Stocks to Buy Next Month? 3 For Your Watchlist
Are these biotech penny stocks to watch on your list for July 2021? The post Best Biotech Penny Stocks to Buy Next Month?
Hot Penny Stocks to Buy? 3 For Your Morning Watchlist
Investing in penny stocks in June? Check these 3 out today The post Hot Penny Stocks to Buy?
4 Robinhood Penny Stocks to Watch in Summer 2021
Best Robinhood penny stocks for Summer 2021? Check these 4 out The post 4 Robinhood Penny Stocks to Watch in Summer 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks....
PIRS Stock: The Big News That Has Pieris Pharma Shares Rising Today
Pieris Pharmaceuticals (PIRS) stock is rising higher on Wednesday after announcing a collaboration agreement with Genentech. The post PIRS Stock: The Big News That Has Pieris Pharma Shares Rising Today ...
Are Options Traders Betting on a Big Move in Pieris (PIRS) Stock?
Investors need to pay close attention to Pieris (PIRS) stock based on the movements in the options market lately.